QQ客服 官方微博 反馈留言

	Targeting the IDO1 pathway in cancer: from bench to bedside
	Liu, Ming*; Wang, Xu; Wang, Lei; Ma, Xiaodong; Gong, Zhaojian; Zhang, Shanshan; Li, Yong*
刊名	Journal of Hematology & Oncology
	2018
卷号	11期号:1页码:100
关键词	3-dioxygenases Clinical trial IDO1 Immunosuppression Immunotherapy Indoleamine 2
ISSN号	1756-8722
DOI	10.1186/s13045-018-0644-y
URL标识	查看原文
WOS记录号	WOS:000440541800001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3331102
专题	中南大学
作者单位	[Liu, Ming] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
推荐引用方式 GB/T 7714	Liu, Ming*,Wang, Xu,Wang, Lei,et al. Targeting the IDO1 pathway in cancer: from bench to bedside[J]. Journal of Hematology & Oncology,2018,11(1):100.
APA	Liu, Ming*.,Wang, Xu.,Wang, Lei.,Ma, Xiaodong.,Gong, Zhaojian.,...&Li, Yong*.(2018).Targeting the IDO1 pathway in cancer: from bench to bedside.Journal of Hematology & Oncology,11(1),100.
MLA	Liu, Ming*,et al."Targeting the IDO1 pathway in cancer: from bench to bedside".Journal of Hematology & Oncology 11.1(2018):100.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。